The National Urban League and League of United Latin American Citizens Urge Express Scripts to Reach Agreement with Walgreens
NEW YORK, Dec. 19, 2011 /PRNewswire/ -- The National Urban League (NUL) and the League of United Latin American Citizens (LULAC) today urged Express Scripts, Inc. (ESI) to resume negotiations and come to an agreement with Walgreens on new contract terms. If an agreement is not reached, millions of Americans, especially in diverse and underserved communities, stand to lose access to pharmacy services on January 1, 2012.
In an open letter to Express Scripts, Marc H. Morial, President and Chief Executive Officer of the National Urban League and Margaret Moran, National President of the League of United Latin American Citizens state that "Walgreens has been a valued partner with the National Urban League and LULAC for many years. Together we have worked to address the health issues, improve health outcomes and reduce health disparities in our communities across the country."
While this is a dispute between companies, open and fair input from communities across the country is critical, as the outcome drastically affects the healthcare options of millions of Americans. NUL and LULAC have a vested interest in ensuring that all people have access to affordable and convenient neighborhood pharmacies. Families and communities across the country deserve a quick resolution that preserves access to care and medicines in their own neighborhoods.
"As the nation's largest pharmacy chain, with nearly 8,000 stores nationwide, Walgreens serves 40 million consumers every week. Walgreens fills an important role in our neighborhoods. In many areas Walgreens is the only pharmacy that can fill health care needs and prescriptions 24 hours a day, seven days a week. This is of great significance to communities that we serve."
For more than 100 years, Walgreens has been committed to serving urban neighborhoods and continues to serve communities throughout the United States where quality health care services are scarce.
As noted in the letter, wit